dawnpowell

1048 POSTS 0 COMMENTS

EAPCI issues consensus statement on ischaemia with non-obstructive coronary arteries

The European Association of Percutaneous Cardiovascular Interventions (EAPCI) has published a co...

First 10-year report of TAVI durability indicates a low rate of structural valve deterioration

Janarthanan Sathanathan (Center for Heart Valve Innovation, St Paul’s Hospital, Vancouver, Canad...

PCR e-Course 2020: Two-year outcomes of deferred revascularisation based on FFR or iFR measurements “virtually identical”

Mid-term data continue to show non-inferiority of resting instantaneous wave-free ratio (iFR) wh...

PCR e-Course 2020: P2Y12 inhibitor monotherapy associated with increased risk of cardiac death after PCI

A subanalysis of the Onyx One study found that cardiac death was significantly higher in patient...

PCR e-Course 2020: Data for Ultimaster reinforce safety and efficacy of device

According to a press release, one-year total population clinical outcome data from e-ULTIMASTER—...

PCR e-Course 2020: Cangrelor provided inferior inhibitor of platelet aggregation than tirofiban in STEMI patients

The FABOLUS FASTER trial, which was presented at PCR e-Course 2020 and simultaneously published ...

PCR e-Course 2020: CoFI system may address microvascular obstruction after primary PCI

Felice Gragnano (Inselspital, Bern University Hospital, Bern, Switzerland) outlined at PCR e-Cou...

PCR e-Course 2020: Routine revascularisation confers no survival advantage over initial medical therapy in patients with stable disease

Sripal Bangalore (New York University Grossman School of Medicine, New York, USA) presented the ...

ACC and SVS Join Forces on Single Vascular Registry

The American College of Cardiology (ACC) and Society for Vascular Surgery (SVS) are collaboratin...

Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

Medtronic has received the CE mark for a one-month dual antiplatelet therapy (DAPT) indication f...

Bicuspid TAVI outcomes as good as those for tricuspid

Clinical and echocardiographic outcomes at 30 days and one year were similar between patients wi...

Vinod Thourani

Mitral and tricuspid valve technologies, aortic valve replacement, and the value of the heart te...

Cardiovascular News Issue 57—June 2020: US edition

COVID-19 linked to a near 40% drop in STEMI cases in US cath labs Survey provides insights in...

Cardiovascular News Issue 57—June 2020

COVID-19 linked to a near 40% drop in STEMI cases in US cath labs Survey provides insights in...

COVID-19: TCT becomes latest conference to go virtual

The annual Transcatheter Cardiovascular Therapeutics (TCT) meeting has become the latest in a long l...

COVID-19 is “here to stay” and new registry will provide important insights

The Society for Cardiovascular Angiography and Interventions (SCAI) and the Canadian Association...

Limited health literacy associated with a higher risk of death in heart failure patients

According to research published in JACC: Heart Failure, patients with heart failure who experien...

Society of Cardiovascular Computed Tomography to present gold medal award to John Lesser

A press release reports that the Society of Cardiovascular Computed Tomography (SCCT) will prese...

COVID-19: NHS staff show signs of mild depression

According to a survey published in the Journal of Occupational and Environmental Medicine, NHS s...

Transcatheter tricuspid valve repair shows promise for reducing heart failure hospitalisations

In JACC: Heart Failure, Mathias Orban (Medizinische Klinik und Poliklinik I, Klinikum der Univer...

COVID-19: “Communities of colour are at ground zero for this crisis”

Several studies have suggested that, across all countries, COVID-19 mortality is higher in peopl...

SCAI 2020: PROTECT III shows placing Impella prior to high-risk PCI associated with lower mortality

Data from more than 1,000 patients presented during the virtual Society for Cardiovascular Angio...

Jeffrey J Popma joins Medtronic as vice president and chief medical officer for coronary, renal denervation, and structural heart businesses

Medtronic has that announced Jeffrey J Popma (Harvard Medical School; Beth Israel Deaconess Medical ...

CE mark PASCAL clip-based system for transcatheter tricuspid repair

Edwards Lifesciences has received the CE mark for the PASCAL transcatheter valve repair system f...

Robotic PCI associated with a 20% reduction in radiation exposure

A study published in Circulation: Cardiovascular Interventions shows that robotic percutaneous c...

SCAI 2020: Strong 10-year performance for Melody transcatheter pulmonary valve

A late-breaking clinical trial presented at the virtual Society for Cardiovascular Angiography a...

Risk factors for cardiovascular disease linked to cognitive decline

Weili Xu (Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical...

Eating is no less safe than fasting prior to cardiac catheterisation

A study presented at the virtual Society for Cardiovascular Angiography and Interventions (SCAI)...

SCAI 2020: Statin therapy plus icosapent ethyl significantly reduces number first and repeat revascularisation

A study presented yesterday at the virtual Society for Cardiovascular Angiography and Interventi...

SCAI 2020: Telemedicine could be used offer remote guidance to STEMI patients

A novel, groundbreaking trial has examined the viability of telemedicine for remote guidance of a ...

PCR announce dates for its online course

PCR has announced a new online initiative—e-Course 2020—that is to run online from 25 June 27 Ju...

SCAI release positional statement on optimal PCI for complex coronary artery disease

The Society for Cardiovascular Angiography and Interventions (SCAI) has published a position sta...

MedAlliance gains CE mark approval for coronary Selution SLR balloon

MedAlliance has announced the award of its second CE mark: Selution SLR 014 percutaneous translu...

Cardiothoracic surgeons are “extremely satisfied” with their jobs

A survey published in The Annals of Thoracic Surgery find that despite being in an intensely dem...

COVID-19: NCDR Chest Pain-MI, CathPCI registries to review effect of virus on heart disease patients

The American College of Cardiology (ACC) is start to collecting COVID-19 data through the NCDR C...

Resolute Onyx matches Orsiro at two years in all-comers’ patients

Two-year data from the BIONYX trial show that all-comer patients who underwent percutaneous coro...

COVID-19: Heart Valve Voice US raises concerns about lack of patient input in recent guidance on restarting elective procedures

According to a statement, Heart Valve Voice US is “deeply concerned” that the patient perspective wa...

COVID-19: Mayo Clinic works with Ultromics to rapidly assess patients with COVID

A joint UK-US research team is applying an artificial intelligence (AI) system to map for the first ...

Positive preclinical results supporting investigational new drug application for anti-inflammatory cell therapy for heart failure

BioCardia has announced data from a recent animal study performed that, according to a press rel...

COVID-19: Anticoagulants may improve survival among hospitalised COVID patients

Corresponding author Valentin Fuster (Mount Sinai Heart, New York, USA) and colleagues report in...

COVID-19: Survey suggests increased operating days may be required to clear elective backlog

  A BIBA MedTech Insights survey indicates that 50% of centres performing structural hea...

COVID-19: Education in the time of coronavirus

Vishal Luther (final year cardiology registrar/ Electrophysiology fellow, Imperial College Healt...

COVID-19: ESC Congress 2020 to become a completely virtual event

The European Society of Cardiology (ESC) is, for the first time in its 70-year history, to hold ...

Study establishes safety and efficacy of ticagrelor monotherapy in acute coronary syndrome patients treated with Orsiro

According to recently presented TICO trial data, a press release reports, patients with acute co...

CE mark for SuperSaturated oxygen therapy

ZOLL Medical has received CE Mark approval to market and distribute its SuperSaturated oxygen (S...

COVID-19: Society of Cardiovascular Computed Tomography to host virtual meeting

The Society of Cardiovascular Computed Tomography (SCCT) has announced plans to hold its annual ...

COVID-19: North American societies provide advice on resuming cardiovascular procedures

The American College of Cardiology (ACC) and other North American cardiology societies, includin...

The top three symptoms of myocardial infarction are same for women and men

complete-revascularisation
A study presented at EAPC Essentials 4 You—a virtual scientific platform of the European Society...

COVID-19: PCR officially cancel EuroPCR 2020

PCR has issued a statement announcing that it is officially cancelling the 2020 physical EuroPCR...

COVID-19: We have used YouTube to encourage STEMI patients to come to hospital

Recent studies have suggested that during the pandemic, there has been a drop in ST-segment elev...

Multivessel PCI has similar outcomes to culprit-vessel only PCI for cardiogenic shock patients when mechanical circulatory support used

A new study has found no significant differences in hospital mortality between multivessel percu...

Using the heart team approach for congenital heart disease benefits both patients and parents

Before the 1940s, the prognosis for babies born with complex congenital heart disease was dismal...

COVID-19: Calls for physicians to address domestic violence during social distancing

Prism Schneider (Cumming School of Medicine, University of Calgary, Calgary, Canada) and others ...

Abiomed acquires novel ECMO developer Breethe

Abiomed (maker of the Impella heart pump) has acquired Breethe, developer of a novel extracorpor...

American Academy of Neurology recommends PFO closure for selected stroke patients

New guidance from the American Academy of Neurology (AAN) recommends the closure of a patent for...

COVID-19: CMS outlines recommendations for restarting non-emergent procedures

On 18 March, the Centers for Medicare & Medicaid Services (CMS) recommended “limiting non-es...

Cardiovascular robotics company secures €40 million series C financing round

Robocath, which designs, develops and commercialises cardiovascular robotic systems for the trea...

Boston Scientific reveals CE mark for Acurate neo 2 in Q1 financial results report

Boston Scientific, according to a press release announcing the company’s Q1 2020 financial resul...

COVID-19: SCAI and CAIC launch registry to provide vital data for managing patients

The Society for Cardiovascular Angiography and Interventions (SCAI) and Canadian Association of Inte...

COVID-19: BHF and NIHR work together to understand why cardiovascular increases risk of virus

A press release reports that the British Heart Foundation (BHF) and the National Institute of He...

FDA Breakthrough Device Designation for novel heart failure therapy

VisCardia has been granted Breakthrough Device Designation from the US Food and Drug Administrat...

COVID-19: LivaNova can modify indications of its cardiopulmonary products to help address virus

LivaNova has announced that several of its cardiopulmonary products are can now be used in the U...

COVID-19: US societies release joint consensus statement on treating myocardial infarction during the pandemic

In the Journal of American College of Cardiology, Ehtisham Mahmud (University of California, San...

COVID-19: Ventilator manufacturers unite to training alliance and create app for frontline workers

A press release reports that several of the world’s ventilator manufacturers have formed a Ventilato...

COVID-19: Terumo BCT’s Mirasol shows efficacy against virus in plasma and platelets

New data suggest that a medical device that uses vitamin B2 and ultraviolet light for treating human...

Pi-Cardia closes a US$27 million financing round led by Sofinnova Partners

Pi-Cardia has closed a US$27 million round of financing, led by Sofinnova Partners. A press rele...

Proximo Medical named as commercialisation partner for Elucid Bioimaging

Proximo Medical has announced a partnership with Elucid Bioimaging, a developer of diagnostic im...

COVID-19: Robotics may help to reduce exposure to virus patients during interventional procedures

Studies have shown that robotic percutaneous coronary intervention (PCI) with the CorPath GRX Sy...

COVID-19: Testing for high-sensitivity cardiac troponin would be beneficial not a hindrance

In response to a recent American College of Cardiology (ACC) review that advocated that troponin...

COVID-19: “Essential” vs. “non-essential” TAVI procedures can be difficult to determine

In the first of a series of webinars focusing on COVID-19, Society for Cardiovascular Angiograph...

COVID-19: How the Egyptian cardiology departments are managing the pandemic

The COVID-19 pandemic is hitting the world hard. Egypt, the most populous country in the Middle ...

Study affirms safety and efficacy of Optimizer system for heart failure

Impulse Dynamics has announced the publication of the FIX-HF-5C2 study in Circulation: Heart Fai...

Pressing on abdomen helped to improve “STEMI” symptoms in rare case

Enrique Ostrzega (University of Southern California, Los Angeles, USA) and colleagues report in ...

COVID-19: FDA authorise blood purification device for treating virus

The US Food and Drug Administration (FDA) issued an emergency use authorisation for a blood puri...

COVID-19: Nearly 40% drop in STEMI cases in US cath labs since March 2020

Woman patient
Santiago Garcia (Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapol...

COVID-19: American Heart Association issue pandemic CPR guidelines

The American Heart Association (AHA) has compiled interim CPR guidelines to help rescuers treat ...

COVID-19: Cotton and surgical masks may be ineffective at stopping spread of virus through coughs

In a brief report in Annals of Internal Medicine, Seongman Bae (Asan Medical Center, University ...

COVID-19: Optimising heart failure management in the patient’s home

Physicians recognised the importance of remote management for heart failure patients long before...

COVID-19: Both ACC and ESC urge patients to seek help if they experience symptoms of a myocardial infarction

In separate statements, the European Society of Cardiology (ESC) and American College of Cardiol...

CE mark for transcatheter system that uses same clip technology as MitraClip

Abbott has received the CE mark for its TriClip transcatheter tricuspid valve repair system. It ...

Mardil Medical completes treatment of third patient in VenTouch device trial

Mardil Medical has announced the successful completion of treatment for the third patient in the...

Shockwave completes enrolment in study of coronary intravascular lithotripsy

Shockwave Medical has completed enrolment in its US Food and Drug Administration (FDA) Investiga...

Cancer patients should not automatically be excluded from TAVI

Ahmed Bendary describes the findings of a meta-analysis published last month that determined out...

Soft robotic heart could be answer to donor heart shortage

A soft robotic heart that is designed to replace the need for a heart transplant is one of four ...

Techno-College Innovation Award for LifeMatrix bioengineering platform

At the 2019 European Association of Cardio-Thoracic Surgeons (EACTS) annual meeting (3–5 October...

COVID-19: Edwards pauses enrolment in mitral and tricuspid trials to allow hospitals to focus on virus

Edwards Lifesciences has temporarily paused new enrolments in its active pivotal clinical trials...

COVID-19: European Commission agrees to postpone new MDR because of pandemic

The European Commission (EC) has adopted a proposal to postpone by one year the date of applicat...

Virtual ACC: Edoxaban non-inferior to warfarin for preventing thromboembolism after surgical bioprosthetic valve replacement

According to Geu-Ru Hong (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei Univ...

Virtual ACC: Newer generations of MitraClip associated with greater reduction in mitral regurgitation than previous version

MitraClip in moderate surgical risk patients
Today at the American College of Cardiology/World Congress of Cardiology’s virtual scientific se...

Virtual ACC: Low-dose colchicine after myocardial infarction is “economically dominant”

During the first Featured Clinical Research session of the virtual American College of Cardiolog...

Virtual ACC: Genotype-guided therapy after PCI does not hit study target

Today, during the Virtual American College of Cardiology (ACC) event (28–30 March, Central Time)...

COVID-19: European Commission looking to postpone new MDR by one year

During a Q&A section of a European Commission (EC) college meeting on 25 March, EC spokesper...

BIBA Briefings: Award for film raising awareness of aortic dissection

A short film (“Today is a Good Day”), which showcases the work of Aortic Dissection Awareness UK...

BBC Newsnight makes fresh claims about allegedly withheld mortality data in EXCEL

The news programme BBC Newsnight has made further claims that the EXCEL investigators “held back...

FDA Breakthrough Device Designation for fully implantable left ventricular assist system

The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Abbott ...

Abbott becomes first company in world to have transcatheter mitral implantation device on market

The Tendyne transcatheter mitral valve implantation (TMVI) system (Abbott) has received the CE mark,...

New randomised study investigating distal radial access, DISCO RADIAL, launches

distal
Terumo has announced the launch of a new randomised clinical trial: the DIStal vs. COnventio...

STS says independent analysis of EXCEL is best opportunity to “get it right for patients”

The Society of Thoracic Surgeons (STS) has issued a statement on the controversy surrounding EXC...

New trial to evaluate role of Impella in preventing heart failure in STEMI patients

impella in preventing heart failure in stemi patients
A pivotal, multicentre clinical trial is exploring the use of an Impella heart pump (Abiomed) to...

BIBA Briefings: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA

Edwards Lifesciences has received the CE mark for its Sapien 3 transcatheter aortic valve implan...

EXCEL leadership refute BBC Newsnight claims in 3,500-word document

Gregg Stone (The Zena and Michael A Wiener Cardiovascular Institute, Icahn School of Medicine at Mou...

BBC Newsnight investigation of EXCEL prompts EACTS to reject 2018 European recommendations on left main disease

  The European Association of Cardio-Thoracic Surgery (EACTS) has withdrawn its support ...

BIBA Briefings: Longest and largest follow-up data for Watchman supports its role in stroke prevention

Data from the CAP and CAP2 registries—which contain the longest and largest follow-up of patient...

ADVERTORIAL: Answering the question of durability is TAVI’s next challenge

Over the past few years, the indications for transcatheter aortic valve implantation (TAVI) have...

ADVERTORIAL: Edwards PASCAL™ Transcatheter Valve Repair System is associated with a “striking” reduction in mitral regurgitation

This content is only for readers outside of the US as it discusses a device that is not FDA appr...

BIBA Briefings: Henry V can inspire us to develop innovative techniques for reducing radiation exposure

During a session on radiation protection technologies at the 2019 Transcatheter Cardiovascular T...

EACTS 2019: Leading cardiothoracic surgeon questions EXCEL trial’s conclusion

Cardiothoracic surgeon David Taggart (Department of Cardiac Surgery, University of Oxford, John ...

FDA approves Evolut PRO+

The US Food and Drug Administration (FDA) has approved the Evolut PRO+ transcatheter aortic valv...

Cardiovascular News Issue 55—September 2019 US edition

In our September issue, we report on the top stories from the 2019 European Society of Cardiology (E...

Cardiovascular News Issue 55—September 2019

In our September issue, we report on the top stories from the 2019 European Society of Cardiology (E...

Cardiovascular News Issue 54—August 2019 US edition

The August issue of Cardiovascular News covers the top stories from EuroPCR 2019, looking at PCR sta...

Cardiovascular News Issue 54—August 2019

The August issue of Cardiovascular News covers the top stories from EuroPCR 2019, looking at PCR sta...

AtriCure agrees to buy LARIAT developer SentreHEART

AtriCure has entered into a definitive agreement to acquire SentreHEART, which developed the LAR...

Novel repositionable TAVI valve has acceptable early clinical outcomes

A new study indicates that the Meridian transcatheter aortic valve implantation (TAVI) valve (HL...

ESC 2019: Registry study supports use of ICDs for primary prevention in patients with heart failure

New data from the SwedeHF heart failure registry indicates that the use of an implantable cardio...

ESC 2019: Two-year findings of MITRA-FR continue to show no prognosis benefit with MitraClip

At the European Society of Cardiology Congress (ESC 2019; 31 August–4 September, Paris, France),...

ESC 2019: Ultrathin strut Orsiro better than thin strut Xience for STEMI patients

One-year data from the BIOSTEMI study, simultaneously published in The Lancet and presented at t...

ESC 2019: Left atrial appendage closure is non-inferior to NOACS for preventing major neurological, cardiovascular, and bleeding events

This morning at the 2019 European Society of Cardiology (ESC) Congress (31 August–4 September, P...

ESC 2019: Prasugrel bests ticagrelor for the management of acute coronary syndromes

Stefanie Schüpke (Deutsches Herzzentrum München, and Technische Universität München, Munich, Ger...

ESC 2019: Abiomed launches Impella SmartAssist platform

At the 2019 European Society Cardiology (ESC) congress (31 August – 4 September, Paris, France),...

Poll favours interventional radiologists to perform mechanical thrombectomy in lieu of neurointerventionalists

According to a BIBA MedTech survey, 52% of neurointerventionalists believe that they are the onl...

FDA approves Sapien 3 Ultra, Sapien 3, and CoreValve for low-risk TAVI

On 16 August, the US Food and Drug Administration (FDA) approved Edwards Lifesciences’ Sapien 3 ...

Edwards Lifesciences drops Centera in favour of focusing on Sapien range

Edwards Lifesciences—in a press statement announcing its global second quarter (Q2) financial re...

Myval: India’s TAVI technology is now going global

The Myval transcatheter aortic valve implantation (TAVI) system, designed and manufactured by Me...

Edwards Lifesciences to discontinue its self-expanding valve Centera

Edwards Lifesciences has announced it has made the “difficult decision” to discontinue its self-...

Edwards Lifesciences issues urgent safety notice for Sapien 3 Ultra

Edwards Lifesciences has issued an urgent safety notice for the latest generation of its Sapien ...

Edwards Lifesciences issues an urgent field safety notice for Centera TAVI system

After receiving reports of difficulty tracking and manipulating the Centera transcatheter aortic...

Zoll Medical acquires TherOx

Zoll Medical, an Asahi Kasei Group Company that manufactures medical devices and related software so...

Patent granted to Valfix Medical for its percutaneous valve and replacement technology

Valix Medical has received a US patent—10,278,820 (percutaneous valve repair and replacement)—fo...

Robotic PCI company adds interventional cardiology experts to its medical advisory board

Robocath has announced that that the well-known interventional cardiologists Michael Haude, Fazi...

Philips announces new advanced automation capabilities for its EPIQ CVx and EPIQ CVxi cardiac ultrasound systems

A Philips press release reports both the EPIQ CVx and EPIQ CVxi now include automated applicatio...

India-designed Myval associated with no device-related mortality at one year

One-year data for the Myval transcatheter aortic valve implantation (TAVI) system indicate it is...

Mentice and Siemens Healthineers aim to bring a virtual patient to the angio-suite

Siemens Healthineers and Mentice have announced a collaboration to fully integrate Mentice’s Vist “V...

Nearly 50% of treatment strategies would change with use of investigational HeartFlow planner

New data show that the use of the investigational HeartFlow Planner—a real-time, non-invasive in...

DSM and SAT enter partnership to develop the first next-generation heart valve

Royal DSM is to collaborate with Strait Access Technologies (SAT) to develop the world’s first durab...

CMS’ update to coverage policy for TAVI provides greater flexibility for hospitals and providers

The Centers for Medicare & Medicaid Services (CMS) has finalised its update the US coverage ...

New trial to compare Watchman FLX to direct oral anticoagulants

The OPTION trial is to compare the compare safety and effectiveness of the next-generation Watch...

US$170m funding for Acutus Medical

A company providing what a press release calls “next-generation electrophysiology technology sol...

Adrian Banning

Adrian Banning (John Radcliffe Hospital, Oxford, UK) initially wanted to fly a Boeing 747 but, aged ...

TVT 2019: PASCAL system may be beneficial for managing tricuspid regurgitation

New data for the PASCAL system (Edwards Lifesciences), which received the CE mark in February 2019 f...

TVT 2019: Purpose-designed temporary pacing guidewire has potential to make implantation of transcatheter heart valves “safer and more efficient”

Speaking during an innovation session at TVT 2019 (12-15 June, Chicago, USA), Mark Hensey (Centr...

TVT 2019: TAVI is “preferred therapy” for low-risk patients

This morning at TVT 2019 (12-15 June, Chicago, USA), in separate presentations, the principal invest...

EuroPCR 2019: Renal denervation linked to reduction in subclinical atrial fibrillation

Data presented at EuroPCR today indicates that renal denervation with the Symplicity system (Med...

EuroPCR 2019: Ultrathin stent demonstrates benefits in small vessels

Late-breaking trial data presented at EuroPCR 2019 (20–24 May, Paris, France) on three year outc...

A “crackdown” on alternative access for TAVI

  The transfemoral approach is—by far—the most desirable access route for transcatheter ...

Majority of cath labs feel burdens of PCI public reports outweigh benefits

Nearly two thirds (64.3%) of cath lab staff believe that the financial/administrative burdens of mee...

Less than half of vein graft interventions use embolic protection

Current US guidelines recommend the use of embolic protection during saphenous vein graft percut...

Triage STEMI patients for ICU after PCI based on reperfusion timing

Patients with ST segment elevation myocardial infarction (STEMI) who undergo percutaneous corona...

Vitros high-sensitivity troponin assay receives CE mark

Ortho Clinical Diagnostics has received the CE mark for its next-generation Vitros high sensitiv...

NeoChord raises additional financing to drive catheter‐based programme development

NeoChord has announced that it has secured additional funding as an extension of its Series D equity...

Biotronik launches PK Papyrus covered coronary stent in the USA

Biotronik has launched the PK Papyrus covered coronary stent system in the United States for use...

Lotus Edge becomes third TAVI device on US market

Boston Scientific has received US FDA approval for its Lotus Edge transcatheter aortic valve imp...

US FDA approve SSO2 Therapy for the management of myocardial infarction

TherOx has received US FDA premarket approval for its SuperSaturated Oxygen (SSO2) Therapy. A press ...

TAVI company Tioga Medical closes US$15M in series A financing

Tioga Medical—a newly formed Shifamed portfolio company—has announced the closing of its series A pr...

PhaseBio receives FDA breakthrough therapy designation for PB2452 for the reversal of the antiplatelet activity of ticagrelor

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS) has announced that the US FDA has granted breakthrough...

Targeted blood pressure management helps to reduce strokes in patients with HVAD

An analysis on the impact of stroke severity in patients receiving the HeartWare HVAD system (Me...

CE mark for the FEops HEARTguide

FEops has received CE mark approval for its FEops HEARTguide. According to a press release, FEop...

Manage the risk of complications in CTO-PCI

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains one of the m...

Reconciling the contrasting findings on MitraClip, and implications for the management of functional mitral regurgitation

Last year, the first two randomised controlled trials (RCT) looking at percutaneous edge-to-edge...

Comics may help patients to better understand coronary interventions

A pilot study, published as a research letter in the Annals of Internal Medicine, has found that...

Prevalence of multiple organ failure among cardiogenic shock patients has steadily increased

Between 2000 and 2014, in the USA, the percentage of patients with acute myocardial infarction c...

ACC 2019: TAVI moves to the mainstream with new findings in low-risk patients

Evidence for the use of transcatheter aortic valve replacement (TAVI) as standard therapy is mountin...

Robert W Yeh

Robert W Yeh (Department of Medicine, Richard A. and Susan F. Smith Center for Outcomes Research...

CRT 2019: Evolut R superior to surgery at one year in intermediate-risk patients

A subanalysis from the SURTAVI trial has found that transcatheter aortic valve implantation (TAV...

CRT 2019: Alert system is safe, quick, and has few complications

The AngelMed Guardian implantable device is as safe as using a pacemaker, with comparably low compli...

MitraClip can be used to treat secondary mitral regurgitation in the USA

MitraClip in moderate surgical risk patients
The US FDA has approved a new indication for percutaneous edge-to-edge repair (MitraClip, Abbott...

Micro Interventional Devices enters strategic alliance with Oscor

Micro Interventional Devices chairman, president and CEO, Michael Whitman, and Oscor president and C...

CardioCel 3D and VascuCel receive regulatory approval in Europe

Admedus has received the CE mark for its CardioCel 3D product portfolio and its next-generation ...

ACC to offer transcatheter valve certification to help hospitals implement best practices

Beginning in mid-2019, hospitals performing transcatheter valve repair and replacement will be able ...

Northwestern Medicine Bluhm Cardiovascular Institute is pioneering the use of artificial intelligenc...

CRT 2019: Early resorption and low complications demonstrated for Magmaris

A press release reports that preliminary data from the BIOSOLVE-IV registry strengthen the clini...

Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study

Innovative Cardiovascular Solutions (ICS) has announced the first clinical use of its next-gener...

Myocardial infarction patients taken directly to heart centres have better long-term survival

Woman patient
According to a large observational study presented at Acute Cardiovascular Care 2019 (2–4 March, Mal...

CRT 2019: Three-year data shows trend towards lower target vessel failure with Orsiro vs. Resolute Integrity and Synergy

Three-year outcome data from the BIO-RESORT randomised controlled trial, which were presented at...

CRT 2019: US FDA approves resting full-cycle ratio for measuring severity of coronary artery blockages

Abbott has announced the US FDA clearance of the resting full-cycle ratio (RFR) diagnostic test to i...

CX 2019 to host first-ever aortic and peripheral virtual reality live cases

The Charing Cross International Symposium (CX) continues its three-year cycle of raising vascular an...

Customising therapy in femoropopliteal revascularisation

 Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about how drug-based ther...

Polymer-free stents have similar performance profiles, except in diabetes

A pooled data analysis comparing the Cre8 amphilimus-eluting stent (Alvimedica) and the BioFreed...

Sapien 3 provides safe and satisfactory access via the transcarotid route

The Sapien 3 device (Edwards Lifesciences) can be safely and effectively used in transcatheter a...

MedAlliance granted “breakthrough device designation” from FDA for its sirolimus-coated balloon

MedAlliance has been granted breakthrough device designation from the US FDA for Selution—a sustaine...

New Australian research and development partnership aims to innovate heart failure care

Biotronik, the University of Newcastle (in Australia), and the John Hunter New England Local Health ...

American College of Cardiology to launch new journal dedicated to cardio-oncology

The American College of Cardiology will expand the Journal of American College of Cardiology (JACC) ...

Augmented reality surgical technology unveiled by Philips and Microsoft

At the MWC (25–26 February, Barcelona, Spain), formerly the Mobile World Congress, Philips unveiled ...

US physicians can now use Resolute to treat chronic total occlusions

Medtronic has received US FDA approval of its Resolute drug-eluting stent platform—including the...

CE mark for R-One robotic-assisted solution for treating coronary diseases

Robocath has obtained CE certification for its R-One robotic device. As a result, it can begin c...

FDA approves Orsiro for use in the USA

  The US FDA have approved Biotronik’s drug-eluting stent Orsiro. A press release states...

ADVERTORIAL: The Edwards Cardioband™ Tricuspid Valve Reconstruction System is associated with considerable improvement in functional outcomes

This content is only for readers outside of the US as it discusses a device that is not FDA appr...

We need to embrace digital education and adapt it to improve patient care—reflections from the ESC

Recent years have seen many advances in education for cardiologists, but little attention has be...

Challenges of conducting a randomised clinical trials to prove the impact of mechanical circulatory support in cardiogenic shock

Mechanical circulatory support is frequently used to stabilise patient haemodynamics in desperate si...

iVascular receives CE mark for Navitian microcatheter

After receiving the CE mark for the device, iVascular launched its Navitian coronary microcathet...

CE mark for PASCAL mitral valve repair system

Edwards Lifesciences now has the CE mark for its PASCAL transcatheter mitral valve repair system. Ac...

ACC to tackle patient, provider access to novel therapies

The American College of Cardiology (ACC) has launched a new initiative that leverages prospective cl...

Philips launches Zenition mobile C-arm platform

Zenition
Philips Zenition, a new mobile C-arm imaging platform from Philips, has launched in the USA, Ger...

Rehab programme after myocardial infarction helps to reduce death

A programme designed to help myocardial infarction patients with the transition from hospital to...

One in five US patients with atherosclerotic cardiovascular disease cannot pay their medical bills

A review, published in the Journal of the American College of Cardiology, of the financial hards...

Long-term function of TAVI valves “is excellent”

Daniel J Blackman (Department of Cardiology, Leeds Teaching Hospital NHS Trust, Leeds, UK) and o...

Leviticus Cardio and Jarvik Heart new fully implanted ventricular assist device

At a press conference held at the National Research Center for Cardiac Surgery in Astana (Kazakhstan...

ADVERTORIAL Early results for HAART 200 and HAART 300 Aortic Annuloplasty Devices are encouraging

The Duke Children’s Pediatric & Congenital Heart Center (Duke University Medical Center, Dur...

The Tricento transcatheter heart valve: A novel approach for the treatment of tricuspid regurgitation

  In this commentary for Cardiovascular News, Stefan Toggweiler writes about how the Tri...

London hospital provides first video consultation service for specialist care in England

The Lewisham and Greenwich NHS Trust (London, UK) has become the first NHS Trust in England (UK)...

Less than a third of Americans known that cardiovascular disease is the biggest cause of death

A new survey by HeartFlow of more than 1,500 adults across the USA shows only 29% of respondents...

Cardiovascular News Issue 52—February 2019 US edition

Our latest issue covers the top stories from TCT 2018, including COAPT, ULTIMATE, and FAST-FFR. We a...

Cardiovascular News Issue 52—February 2019

Our latest issue covers the top stories from TCT 2018, including COAPT, ULTIMATE, and FAST-FFR. We a...

US FDA grant premarket approval to Manta vascular closure device

Teleflex has received premarket approval (PMA) from the US FDA for the Manta vascular closure de...

First trial of in-heart micro device for left atrial pressure monitoring launched

Vectorious Medical Technologies has announced the initiation of the VECTOR-HF first-in-human (FI...

PreludeSync distal compression device now available globally

The PrecludeSync Distal (Merit Medical) is now available in the US, European, Middle Eastern, Af...

Registry data for Biotronik’s bioresorbable scaffold Magmaris supports its roll-out into clinical practice

Preliminary data from the BIOSOLIVE-IV registry are consistent with the favourable safety outcom...

ADVERTORIAL: “We are now at a new era of TAVI where we have very high rates of device success”

CAUTION: The ACURATE neo aortic valve system is CE marked. In the USA, it is an investigational ...

CE mark for cloud-based monitoring platform Impella Connect

Abiomed has achieved the CE mark for Impella Connect, which—a press release reports—is the first...

German NUB Status 1 designation for Neovasc Reducer renewed

Neovasc has announced that the Institut für das Entgeltsystem im Krankenhaus (InEk)— the German Inst...

Editors-in-chief of major cardiovascular journals claim medical misinformation puts “lives at stake”

The editors-in-chief of major cardiovascular journals—of both US and European societies—have com...

The British Heart Foundation’s “Big Beat Challenge” is now accepting proposals

The British Heart Foundation (BHF) has announced that it is now accepting proposals for its Big Beat...

FDA IDE approval for safety and feasibility clinical trial of Cor Tricuspid ECM valve

CorMatrix Cardiovascular has received US FDA approval of an early feasibility study investigational ...

Absence of known cardiovascular risk factors increases risk of sudden cardiac arrest in the setting of STEMI

Data from the e-MUST study show that the absence of known cardiovascular risk factors is an inde...

TAVI-induced bundle branch block and permanent pacemaker implantation are “not benign”

New data indicate that patients who develop bundle branch block (BBB) and/or require a new perma...

Increased BMI associated with significant increase in radiation exposure to physicians

Ryan D Madder (Frederik Meijer Heart and Vascular Institute, Spectrum Health, Grand Rapids, USA)...

Meta-analysis shows FFR-guided PCI reduces myocardial infarction

A meta-analysis of individual patient-level data from FAME 2, DANAMI-PRIMULTI and Compare-Acute ...

More work needed to “untangle reasons” for gender gap in cardiovascular research

Writing in Circulation: Cardiovascular Quality and Outcomes, David Ouyang (Stanford University, ...

The SYNTAX score should not be used to choose between CABG and PCI in diabetic patients with multivessel disease

A post-hoc analysis of FREEDOM (Future revascularisation evaluation in patients with diabetes me...

BioCardia submits 510(k) application to US FDA for its Avance steerable introducer for transseptal access to heart

BioCardia has announced its 510(k) submission for US FDA clearance of the Avance steerable intro...

Merit releases Prelude IDeal hydrophilic sheath

Merit Medical has announced the release of the Prelude IDeal hydrophilic sheath Introducer in Europe...

US District Court for the District of Delaware rules that Sapien 3 infringes a Boston Scientific patent

A jury in the US District Court for the District of Delaware determined that the Boston Scientif...

Abiomed invests $15 million in Shockwave Medical

A press release reports that Abiomed is to invest US$15 million in Shockwave Medical and the two...

Edwards Lifesciences to collaborate with Bay Labs to use AI software to improve detection of heart disease

Edwards Lifesciences is to work with Bay Labs on improving the detection of heart disease. The p...

Women wait for longer before calling for help when experiencing heart attack symptoms

Woman patient
Matthias Meyer (Triemli Hospital, Zurich, Switzerland) and others report in European Heart Journ...

First-in-human “remote PCI” performed

CorPath technology has been successfully used in the first-in-human telerobotic intervention stu...

HeartFlow initiates PRECISE randomised clinical trial

HeartFlow has announced the start of the PRECISE (Prospective randomised trial of the optimal ev...

Draft NICE guidance supports use of percutaneous mitral valve repair

MitraClip in moderate surgical risk patients
In draft recommendations, England’s National Institute for Health and Care Excellence (NICE) giv...

In some cases, we are not doing PCI in the right patients

 “The real question is: who should get percutaneous coronary intervention (PCI)? I do not believe ...

The first 60 years of cardiac pacing

Sixty years ago, the first pacemaker implant was made in Stockholm, Sweden (Senning & Elmqvi...

Fantom bioresorbable scaffold implanted for the first time in Italy

Reva Medical announced the first implant of its recently launched Fantom Encore bioresorbable sc...

First implant of Pascal transcatheter mitral valve repair device performed in CLASP IID trial

The first implant of the Pascal mitral valve repair device (Edwards Lifesciences) in the CLASP IID p...

TAVI-proof procedures and device designs

Transcatheter aortic valve implantation (TAVI) is now a well-established treatment for aortic st...

JenaValve receives FDA approval for expanded IDE enrolment in the treatment of patients with severe aortic stenosis and severe aortic regurgitation

JenaValve has received US FDA approval of expansion of its investigational device exemption (IDE...

Personalised ultrasound scan showing atherosclerosis helps reduce cardiovascular risk

Ulf Näslund (Umeå University, Umeå, Sweden) and others report in The Lancet that sharing pictori...

Quidel receives CE mark for its TriageTrue high sensitivity troponin I test

Quidel has received the CE mark for its TriageTrue high sensitivity troponin I test for the quantita...

WeHealth by Servier and MobioSense form a partnership to develop digital portable myocardial infarction detection test

WeHealth by Servier, Servier Group’s e-health Business unit, and MobioSense, a leading semiconductor...

American College of Cardiology New York Cardiovascular Symposium to bring together top cardiologists

The American College of Cardiology New York Cardiovascular Symposium will be held 7–9 December midto...

Presence of left bundle branch block significantly increases risk of pacemaker implantation after TAVI

Quentin Fischer (Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Qu...

Orsiro may be the new benchmark for comparison in drug-eluting stent trials

At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego,...

BASILICA: A new approach for preventing coronary obstruction in TAVI

Insufficient blood flow towards the coronary vasculature following transcatheter aortic valve im...

US FDA plan shakeup of its 510(k) clearance programme

The US FDA has announced plans to modernise its 510(k) clearance programme for approving medical...

The resurgence of renal denervation

More than ever before, arterial hypertension represents one of the greatest health threats and c...

EACTS 2018: From bench to bedside: Roundtrip for cell therapy in heart disease

The study of stem cells in regenerative medicine is a growing field of basic and clinical resear...

AHA 2018: Efficacy and safety of PCI with Ti-no coated bio-active stents presented

The results of the meta-analysis pooling all existing randomised controlled trials comparing Ti-...

Pulmonary artery denervation: A novel approach to managing pulmonary hypertension

According to the results of PADN-5, pulmonary artery denervation (PADN) is associated with signi...

Frail, older patients have 50% increased risk of bleeding during hospitalisation for myocardial infarction

John A Dodson (New York University School of Medicine, New York, USA) and others report in JACC:...

Launch of Sapien 3 Ultra hampered by Boston Scientific dispute

The CE mark has been granted to the Sapien 3 Ultra (Edwards Lifesciences) transcatheter aortic v...

Bay Labs and Northwestern Medicine enrol first patient in study using AI software to improve heart disease detection

Bay Labs and Northwestern Medicine have announced that the first patient has been enrolled in a ...

HeartFlow receives national reimbursement approval in Japan

The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the recommendation by the Cen...

TCT 2018: Multivessel NIRS is feasible, safe and can predict future events

Ron Waksman The Lipid Rich Plaque (LRP) study indicates that cardiac patients with a high li...

AHA 2018: Early invasive strategy without pretreatment significantly reduces recurrent ischaemic events in NSTE-ACS patients

Data from the EARLY randomised trial indicate that patients with non-ST-segment elevation acute ...

AHA 2018: Pilot study paves way for future evaluation of delaying reperfusion in STEMI patients

A pilot study comparing a strategy of left ventricular unloading with the Impella CP device (Abi...

AHA 2018: REGROUP trial

In this video from the European Society of Cardiology, Roxana Mehran (Zena and Michael A. Wiener Car...

US FDA approve new study of Medtronic’s Spyral renal denervation system

The FDA have given Medtronic approval to begin a clinical trial to evaluate the Symplicity Spyra...

Vivasure Medical announces launch of the PerQseal large bore closure device

Vivasure Medical has announced the European launch of the PerQseal closure device for large-bore...

NeoChord announces US$25 Million Series D financing to accelerate development of two transcatheter chordal repair programmes

NeoChord has announced that it has completed a US$25 million Series D equity financing. Proceeds...

AHA 2018: Study shows AliveCor phone app can effectively identify STEMI with nearly the same accuracy as a standard ECG

An international study, led by researchers from the Intermountain Medical Center Heart Institute...

First patient in Hong Kong receive treatment with coronary Orbital Atherectomy System

The first patient in Hong Kong has been treated with the Diamondback 360 coronary Orbital Athere...

Mark Schwartz become vice president of Clinical Affairs at BioCardia

BioCardia has announced that Mark Schwartz—a 25-year veteran of cardiovascular device development—ha...

TCT 2018: Sham-controlled trial indicates indirect annuloplasty reduces mitral regurgitation

REDUCE-FMR indicates that indirect annuloplasty with the Carillon device (Cardiac Dimensions) is...

Cordis launches Mynx Control vascular closure device in the USA

Cordis, a Cardinal Health company, has launched its Mynx Control vascular closure device onto th...

Fantom Encore launched onto market

Reva Medical announced the commercial launch of the Fantom Encore bioresorbable scaffold and the...

First US implantations of TriCinch Coil tricuspid valve repair system performed

4TECH has initiated its US early feasibility study, following receipt of approval from the US FD...

Colder air and reduced sunshine increases risk of myocardial infarction

A new study indicates that low air temperature, low atmospheric air pressure, high-wind velocity...

Atrial fibrillation related to PFO closure occurs early and is transient

A new meta-analysis of patients undergoing percutaneous closure of patent foramen ovale (PFO) af...

New drug formulation could help people undergoing heart surgery

According to a press release, Raimondo Ascione, Saadeh Suleiman (Bristol Heart Institute, Univer...

BioCardia and CellProThera to partner for clinical trial and marketing in Singapore of early stem cell therapy

CellProThera and BioCardia announced an agreement to expand their current collaboration to the S...

TCT 2018: Durable tricuspid regurgitation reduction with MitraClip

Data from the TriValve Registry—an international multicentre, retrospective, multidevice, regist...

TCT 2018: Severe prosthesis-patient mismatch linked to increased mortality at one year

The largest study to date of prosthesis-patient mismatch following transcatheter aortic valve im...

iVascular acquires 10% of NaviGate Cardiac Structures for US$10 million

The collaboration agreement between iVascular and NaviGate Cardiac Structures (NCSI) has been fo...

US FDA approve HeartMate 3 heart pump for advanced heart failure patients not eligible for a heart transplant

The HeartMate 3 left ventricular assist device has received US FDA approval as a destination the...

Single-use, high-definition, miniature camera unveiled at Asia Pacific MedTech Forum 2018

At Asia Pacific MedTech Forum 2018 (9-10 October, Singapore), Cambridge Consultants demonstrated...

First patient enrolled in STTAR study of MIA—minimally invasive annuloplasty

Micro Interventional Devices announced the world's first percutaneous implantation of its MIA, minim...

Caristo Diagnostics launched to commercialise new coronary CT image analysis technology

Caristo Diagnostics, an Oxford University spinout company, has been launched to commercialise a new ...

Rivaroxaban gets FDA approval for treatment in CAD or PAD

Rivaroxaban, brand name Xarelto (Janssen), has received approval by the US Food and Drug Adminis...

TMVI with Tiara valve may be safe and feasible for patients with prior aortic valve replacement

A new study indicates that transcatheter mitral valve implantation (TMVI) with the Tiara valve (...

Risk of death with unrecognised myocardial infarction equal to that with recognised myocardial infarction by 10 years

Tushar Acharya (National Heart, Lung, and Blood Institute, National Institutes of Health, Bethes...

FDA approve TSP Crosser transseptal access system

Transseptal Solutions has received FDA 510(k) clearance for its TSP Crosser transseptal access s...

Teleflex buys vascular closure company Essential Medical

Teleflex has acquired Essential Medical, which has developed and commercialised the CE marked Ma...

US trial of Edwards’ self-expanding Centera valve begins

Edwards Lifesciences has commenced the US pivotal trial that will study its self-expanding Cente...

Only one third of patients in China receive cardiac rehabilitation

Research presented at the 29th Great Wall International Congress of Cardiology (GW-ICC) meeting ...

TCT 2018: IVUS-guided PCI reduces target vessel failure in all-comers population

Jun-jie Zhang (Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nan...

Heart Research UK award £250,000 to researchers developing AI test for coronary heart disease

UK-based charity Heart Research UK has given a Novel and Emerging Technologies (NET) Grant of £250,0...

The US should follow Europe’s lead and change guidelines on embolic protection in saphenous vein grafting

The revised European Society of Cardiology (ESC) myocardial revascularisation guidelines have do...

ADVERTORIAL: Unique design and features of the ACURATE neo (TM) enable safe and efficient procedures

This content is only for readers outside of the US as it discusses a device that is not FDA appr...

Olaf Wendler

Olaf Wendler (lead for Cardiothoracic Surgery, King’s Health Partners, and chair of the Heart and ...

Venus Medtech to buy cerebral protection device company Keystone Heart

Venus Medtech has signed an agreement to acquire Keystone Heart, a privately-held medical device com...

Megha Prasad selected as SCAI-Women in Innovations CHIP Fellowship

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced that Megha Pra...

TCT 2018: Orsiro continues to have lower rates of target lesion failure than Xience

Two-year data from the BIOFLOW-V randomised trial—which compared a sirolimus stent with a biodeg...

TCT 2018: One-year real-world results show Portico TAVI system reduces severe aortic stenosis

According to one-year results from the PORTICO I study, which were presented during a late-breaking ...

TCT 2018: Longest-term data to date for CoreValve study show excellent valve durability out to five years

New data presented at 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 Septem...

TCT 2018: Use of Impella in cardiogenic shock patients associated with relative 24% increase in survival

A new analysis of data from the Impella (Abiomed) Quality (IQ) Database shows a relative increas...

TCT 2018: LEADERS FREE II confirm favourable results for BioFreedom

The primary endpoint results of the LEADERS FREE II trial were presented at the 2018 Transcathet...

TCT 2018: Restore drug-coated balloon matches Resolute for small vessel lesions

Data presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 Septem...

TCT 2018: FFRangio may provide a faster and easier approach to physiological assessment

The FAST-FFR trial, which was presented at the 2018 Transcatheter Cardiovascular Therapeutics (T...

TCT 2018: Audience claps as COAPT shows MitraClip reduces HF hospitalisations

Delegates at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21-25 September, ...

TCT 2018: Lower rate of stent thrombosis with Resolute Onyx vs. Orsiro

Data presented yesterday at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21...

Cardiovascular News Issue 51—September 2018 US edition

In our latest issue, we report on the top stories from the 2018 ESC Congress—including MITRAL.FR, CU...

Cardiovascular News Issue 51—September 2018

In our latest issue, we report on the top stories from the 2018 ESC Congress—including MITRAL.FR, CU...

US FDA approve study of CoreValve Evolut in low-risk patients with bicuspid valves

The US FDA has approved an investigational device exemption (IDE) to initiate a single-arm study...

First patient enrolled in CARILLON pivotal trial

Cardiac Dimensions has announced the company has randomised its first patient in the CARILLON pivota...

PCR LV 2018: One-year results of VIVA confirm safety and efficacy of valve-in-valve procedures with CoreValve

Speaking at PCR London Valves (9–11 September, London, UK) Didier Tchétché (Clinique Pasteur, Toulou...

PCR LV 2018: Early discharge feasible for unselected TAVI patients

Data from the multicentre FAST-TAVI trial indicate that early discharge—discharge within 72 hour...

PCR LV 2018: Favourable outcomes for next-generation Acurate neo2 TAVI system

A new study evaluating the safety and performance of the Acurate neo2 (Boston Scientific) transc...

Onyx One Clear study starts in USA and Japan

Medtronic has announced the start of the Onyx ONE Clear Study in the USA and Japan that will eva...

US FDA approves PK Papyrus stent for coronary perforations

The US FDA has approved the PK Papyrus covered coronary stent system (Biotronik) under Humanitar...

Two patients have been implanted with latest-generation of integrated ICE delivery system

Two patients have been successfully treated with Millipede’s latest-generation delivery system that ...

TCT 2018: Infraredx to present results of the LRP study

Results from the highly anticipated LRP (Lipid-Rich Plaque) study will be presented during a lat...

TCT 2018: Corindus to feature the CorPath GRX system at conference

Corindus Vascular Robotics is to feature its CorPath GRX system at the 2018 Transcatheter Cardio...

SCAI mourns past president Joseph D Babb

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced the death of Josep...

BTG buys Novate Medical

BTG has announced it has acquired Novate Medical (“Novate”), a medical device company focused on the...

Gore buys transcatheter mitral chordal repair technology

Gore has acquired Pipeline Medical Technologies—a privately held medical technology company focused ...

First patients enrolled in trial of MobiusHD for drug-resistant hypertension

Vascular Dynamics has revealed that enrolment of the first patients in an FDA-approved and best-...

ESC 2018: TMVI associated with “excellent outcomes” for valve-in-valve procedures

New results from the TMVR (Transcatheter mitral valve replacement) Registry show that patients w...

SIS Medical to launch three innovative balloon catheters

SIS Medical is to launch three new models of its balloon catheters—EasyT, NIC 1.1 hydro and NIC Nano...

The number of metallic layers affects efficacy of drug-coated balloons for in-stent restenosis

Hiroto Yabushita and colleagues report in Circulation: Cardiovascular Interventions that drug-co...

ESC 2018: More evidence that FFRCT is an effective approach for identifying patients who do not require further intervention

Bjarne L Nørgaard (Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark) and co...

Patients with new-onset atrial fibrillation after TAVI have highest risk of complications

Amit N Vora (Duke University Medical Center/the Duke Clinical Research Institute, Durham, USA) a...

ESC 2018: First US FDA-approved study shows TAVI is safe for low-risk patients

The LRT (Low Risk TAVR) trial did not find any significant differences in the rate of all-cause ...

ESC 2018: Novel imaging biomarker can predict risk of cardiac mortality

Milind Desai (Cleveland Clinic, Cleveland, USA) and colleagues have identified a novel imaging bioma...

ESC 2018: Positive one-year results for Interatrial Shunt Device

One-year follow-up data from the REDUCE LAP-HF I clinical study of the Interatrial Shunt Device (IAS...

ESC 2018: All-cause mortality in cardiogenic shock multivessel PCI only increased during first 30 days

One-year data from the CULPRIT-SHOCK trial indicate that there is no significant difference in all-c...

ESC 2018: Ticagrelor monotherapy approach does not challenge current DAPT approach

The GLOBAL LEADERS trial, simultaneously published in the Lancet and presented at the 2018 Europ...

ESC 2018: No difference in MACE between drug-coated balloons and drug-eluting stents for de novo lesions in small vessels

The 12-months results of the BASKET-SMALL 2 study, which were presented at the 2018 European Society...

ESC 2018: Higher all-cause mortality with Orsiro at five years than with Xience

According to the five-year results of the BIOSCIENCE trial, sirolimus-eluting stents with a biod...

ADVERTORIAL: Rethinking the future of cardiology imaging

This content is only for readers outside of the USA In an environment with growing demand for...

ESC 2018: MitraClip makes “absolutely no difference” for the prognosis of secondary mitral valve regurgitation

The first randomised controlled trial to compare percutaneous edge-to-edge repair (MitraClip, Ab...

Revising the National Coverage Determination for TAVI: The real barrier to care is not volume requirements

Recently the Centers for Medicare and Medicaid Services (CMS) reopened the National Coverage Det...

ESC 2018: Greater use of PCI for high SYNTAX score patients may explain higher rate of all-cause death with FFR in FUTURE

The final results of the FUTURE (Functional testing underlying revascularisation) trial indicate...

Simultaneous TAVI and left atrial appendage closure is feasible

Thomas S Gilhofer (University Heart Center, Department of Cardiology, University Hospital Zurich...

ESC 2018: DAPT score “not generalisable” to a nationwide population

A new study has found that the dual antiplatelet therapy (DAPT) score, which is recommended by b...

ESC 2018: Non-atherosclerotic spontaneous coronary artery dissection predominantly affects young to middle-aged women

Data from the Canadian Spontaneous Coronary Artery Disease (CanSCAD) study indicate that the maj...

ESC 2018: British Heart Foundation to provide £30m for innovation in heart disease

At the 2018 European Society of Cardiology (ESC) Congress (25–29 August, Munich, Germany), Briti...

Cerner and Duke Clinical Research Institute collaborate on new app for calculating cardiac risk

Cerner has collaborated with Duke Clinical Research Institute to develop the atherosclerotic cardiov...

ESC 2018: Siemens Healthineers showcase Magnetom Sola Cardiovascular Edition

At the 2018 European Society of Cardiology (ESC) Congress (25–29 August, Munich, Germany), Siemens H...

ESC 2018: Cardioskin launched

WeHealth, by Servier, has launched Cardioskin—a connected solution that is designed to function as a...

Bayer announces new licensed indication for use of Xarelto in patients with coronary artery disease

Xarelto, co-administered with aspirin, is indicated in the EU for the prevention of atherothromb...

Twenty thousand patients have now been treated with RenalGuard therapy

RenalGuard Solutions has announced the treatment of 20,000 patients with RenalGuard for the prev...

More than 100,000 people now know hands-only CPR thanks to AHA programme

More than 100,000 people have been trained in hands-only cardiopulmonary resuscitation (CPR) sin...

Juan F Granada

Juan F Granada (president and CEO, Cardiovascular Research Foundation, New York, USA) wanted to ...

ClearFlow awarded group purchasing agreement for the chest drainage products category with Premier

ClearFlow has been awarded a group purchasing agreement—chest drainage contract: Contract # PP-OR-15...

Philips launches new cardiac ultrasound solutions with anatomical intelligence

Philips has introduced the EPIQ CVx cardiovascular ultrasound system. Built on the EPIQ ultrasound p...

Cardiovascular News Issue 50—August 2018 US edition

In this edition (Issue 50), we report on the key studies from EuroPCR 2018—SPYRAl HTN-ON, ORBITA FFR...

Cardiovascular News Issue 50—August 2018

In this edition (Issue 50), we report on the key studies from EuroPCR 2018—SPYRAl HTN-ON, ORBITA FFR...

ADVERTORIAL: Edwards’ CardiobandTM Tricuspid Valve Reconstruction System: A new option for under-treated patients

This content is only for readers outside of the US as it discusses a device that is not FDA appr...

The risks and benefits of exercise after a myocardial infarction

In a new position paper, published in the European Heart Journal, the Sports Cardiology Section ...

Novel Ultraseal device is a feasible option for left atrial appendage closure

A feasibility study of a novel left atrial appendage device (Ultraseal, Cardia) indicates that t...

Three-quarters of patients have sustained results at very long-term follow-up after percutaneous balloon mitral valve valvuloplasty

Rafael A Meneguz-Moreno (Department of Interventional Cardiology, Instituto Dante Pazzanese De C...

“No option” for revascularisation in refractory angina does not mean never

Data from OPTIMIST (Options in myocardial ischemic syndrome therapy) registry indicate that a qu...

FDA sends letter warning about mortality and risks with the Syncardia TAH-t Companion 2 Driver

The US FDA has sent a letter to transplant surgeons and cardiologists about the Syncardia tempor...

Enrolment in FAST-FFR trial completed early

CathWorks has announced that its FAST-FFR trial is fully enrolled ahead of schedule. The trial i...

Chronic kidney disease should not be a barrier to TAVI

The first study to compare the use of transcatheter aortic valve implantation (TAVI) with conser...

Re-evaluate use of anticoagulation in patients with atrial flutter

A new study, published in JAMA Network Open, indicates that patients with atrial flutter have a ...

“Communication is key” when managing patients who seek discharge against medical advice

Chun Shing Kwok (Keele Cardiovascular Research Group, Keele University, Stroke-on-Trent, UK) and...

Increased rate of acute myocardial infarction during pregnancy linked to increase in older mothers

A new study published in Mayo Clinical Proceedings indicates that the rate of acute myocardial infar...

Female acute myocardial infarction patients experience worse outcomes when treated by male physicians

Brad N Greenwood (Carlson School of Management, University of Minnesota-Twin Cities, Minneapolis...

“Tricuspidisation” could be a potential approach to performing TAVI in certain patients with bicuspid valves

At present, a bicuspid aortic valve is seen as a relative contradiction for transcatheter aortic...

Patient enrolment in US early feasibility study of Everdur TAVI device initiated

JenaValve has announced initiation of patient enrolment in its early feasibility study (EFS) of ...

PRECLUDE study of Caisson TMVI system concludes

LivaNova has announced the conclusion of the PRELUDE feasibility study for its Caisson transcatheter...

Safety and efficacy results of REDUCE study published in International Journal of Cardiology

The manuscript “Safety and efficacy of the Reducer: A multicentre clinical registry—REDUCE study...

Boston Scientific closes acquisition of Claret Medical

Boston Scientific has announced that it has recently closed its acquisition of Claret Medical, which...

New research links even low levels of air pollution with serious changes in the heart

Researchers have found that people exposed to air pollution levels well within UK guidelines have ch...

VisONE system for heart failure implanted for first time

VisCardia has announced the first implant of its VisONE implantable system for heart failure, an...

CE mark and US FDA approval for RadialSeal introducer kit

Integer Holdings has received US FDA and CE mark approval for its new radial access introducer, ...

Infraredx launches Makoto intravascular imaging system and Dualpro IVUS+NIRS catheter in Japan

Infraredx has announced the Makoto intravascular imaging system, and accompanying Dualpro intrav...

US FDA approval for SynchroMed II implantable system for treating pulmonary arterial hypertension

Medtronic has received US FDA approval for its implantable system for Remodulin to treat patients wi...

Bayer receives positive CHMP opinion for rivaroxaban for patients with coronary artery disease

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...

Invasive strategy provides better outcomes for very elderly patients with NSTEACS

A study in EuroIntervention indicates that very elderly patients—mean age 84.3 years—with non-ST...

Marital status may influence risk of cardiovascular outcomes after myocardial infarction

Chun Wai Wong (Cardiovascular Research Group, Keele University, Stroke-on-Trent, UK) and others ...

On the fence result for initial CMS vote about TAVI volume requirements

A Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) panel of the Centers fo...

Abbott launches trial of its Tendyne transcatheter mitral valve implantation device

Abbott has initiated a pivotal clinical study in the USA of its Tendyne transcatheter mitral val...

Siemens Healthineers transforms care delivery with innovative new tests for faster diagnosis of myocardial infarction

Siemens Healthineers has announced it is helping to shorten the time doctors can diagnose a life...

Benefit of epinephrine in out-of-hospital cardiac arrest countered by its neurologic effects

Data from PARAMEDIC2 (Prehospital assessment of the role of adrenaline: Measuring the effectiven...

Nitroglycerin may be a safe, effective, and economic approach of reducing risk of radial arterial occlusion

Yequn Chen (Department of Cardiology, First Affiliated Hospital of Shatou University Medical Col...

“Remote PCI” successfully performed 100 miles away from the cath lab

Corindus Vascular Robotics has announced that Ryan Madder (Spectrum Health, Ludington, USA) has ...

Advance CS coronary sinus infusion catheter used for the first time

Cook Regentec has announced the first clinical use in the USA of the Advance CS coronary sinus infus...

Boston Scientific to buy cerebral protection system company

Boston Scientific has signed an agreement to acquire Claret Medical, which developed and commerciali...

Reva’s Fantom scaffold is now being distributed in Italy

Reva is expanding commercial access to the Fantom bioresorbable scaffold with a new distribution...

“Wait-and-see” is not an option with the new device regulations

The new EU Medical Device Regulation (MDR) was officially published on 5 May 2017 and entered in...

Cardiovascular Systems signs international distribution agreement with OrbusNeich

Cardiovascular Systems, Inc. (CSI) has signed an exclusive international distribution agreement ...

Societies launch joint report on TAVI

The 2018 American Association for Thoracic Surgery (AATS), the American College of Cardiology (ACC),...

Creavo launches largest US study of its kind

A new cardiac diagnostic device (Vitalscan) aimed at helping physicians rule out active ischaemi...

US FDA clearance for TEECAD system for aiding transoesophageal echocardiography

Visura Technologies has received 510(k) clearance from the US FDA for its transoesophageal echoc...

MedShr: A physician-designed online platform for case discussion

MedShr, which now has more than 500,000 physician users in 180 countries, is an online platform ...

Leaflex Performer: A non-implant based treatment for aortic stenosis

Given sufficient time, all bioprosthetic valves fail—whether they are surgical or transcatheter ...

Next-generation of MitraClip approved for use in the USA

MitraClip in moderate surgical risk patients
Abbott has received approval from the US FDA for a next-generation version of its MitraClip hear...

Consider the transaortic approach when faced with difficult iliofemoral anatomy

The first propensity-matched comparison between the transaortic approach and the transfemoral ap...

Malnourished patients have a three-fold risk of mortality after aortic valve replacement

New data from the FRAILTY-AVR study indicate that mortality—both at 30 days and at one year—is s...

Funding for Neptune left ventricular assist device

A press release reports that the CALYPSO programme will receive 14 million euros to develop CorW...

CPT code for CathWorks’ 3D FFRangio wire free system

CathWorks has received a new CPT code 0523T for its non-invasive, 3D FFRangio system, which is d...

Otsuka Medical Devices, Otsuak Holdings, and ReCor Medical to merge

Otsuka Holdings, Otsuka Medical Devices, and ReCor Medical have signed a merger agreement pursua...

New way to regenerate hearts after myocardial infarction identified

Researchers funded by the British Heart Foundation have identified how a new treatment in mice c...

ADVERTORIAL: Edwards Cardioband™ Mitral Valve Reconstruction System—Reliably addressing annular dilatation

This content is only for readers outside of the US as it discusses a device that is not FDA appr...

The “absolute priority” is to develop onco-cardiology guidelines to help clinicians

In a “Call to action”, published in the Journal of American College of Cardiology, Tochi M Okwuo...

TVT 2018: New-generation TAVI devices perform well in patients with large annuli

A new study indicates that transcatheter aortic valve implantation (TAVI) with a new-generation ...

HeartWare HVAD system receives US FDA approval

Medtronic has received United States Food and Drug Administration (FDA) approval for a less-invasi...

Cardiac Myosin-binding Protein C: Improving chest pain triage by using a novel marker of myocardial injury

The diagnosis of acute myocardial infarction and, therefore, chest pain triage has become increa...

Leaflet thrombosis is not a predictor of stroke or all-cause mortality in the medium term

The largest study to date to systematically review outcomes associated with leaflet thrombosis a...

Corwave announces issuance of US Patent Covering its implantable left ventricular assist device leveraging the wave membrane technology

CorWave has announced that it has obtained patent no. US 9,968,720 B2 on May 15, 2018 from the US Pa...

Cardiac hybrid imaging is an effective tool for predicting myocardial infarction

According to a study published in Radiology, cardiac hybrid imaging with computed tomography (CT) an...

Endotronix joins AHA’s Center for Health Technology & Innovation to broaden the use of guideline-based care for heart failure patients

Endotronix has announced they have joined the American Heart Association’s Center for Health Technol...

Lexington Biosciences concludes initial HeartSentry clinical study

Lexington Biosciences has announced the completion of the initial HeartSentry study, conducted at Sa...

Largest insurer in USA now covers HeartFlow Analysis

HeartFlow has announced that UnitedHealthcare now covers its HeartFlow FFRct Analysis system; Un...

AorTech sign development agreement with Vascular Flow Technologies

AorTech, a biomaterials and medical device IP company, has signed a development agreement with Vascu...

ACC’s ACTION registry to become Chest Pain—MI Registry

The American College of Cardiology’s (ACC) ACTION Registry is changing its name to the Chest Pai...

TVT 2018: Tiara TMVI device featured in live case

Neovasc announced that its Tiara transcatheter mitral valve implantation (TMVI) device was featu...

Novel “smart stent” can tell physicians when restenosis is occurring

Kenichi Takahata (University of British Columbia, Vancouver, Canada) and colleagues have designe...

Third-generation drug-eluting stents and beyond: Where were we, where are we, and where we are heading

Second-generation drug-eluting stents resolved the issues of late and very late stent thrombosis...

Carotid disease is not a risk factor for stroke or death in TAVI patients

A new study, published in Circulation: Cardiovascular Interventions, shows that one fifth of pat...

ADVERTORIAL: ACURATE neo: A “very safe” TAVI system providing “extremely good results in almost all patients”

This content is only for readers outside of the US as it discusses a device that is not FDA appr...

TVT 2018: Positive results for Manta large bore closure device

Results from the SAFE MANTA IDE clinical trial—the first pivotal trial for a dedicated large bor...

One in five UK doctors say under staffing has affected patient safety

The annual census of UK consultants and higher speciality trainees—Focus on Physicians 2017–18—i...

Implantation of JenaValve successful in initial patients enrolled in CE mark study

JenaValve Technology has announced the initiation of patient enrolment and implantations associa...

Bisexual men have more risk factors for cardiovascular disease

According to a study published in LGBT Health, bisexual men have a higher risk for cardiovascula...

Physicians are more willing to tolerate uncertainty about coronary artery disease testing if risk of malpractice is less

Steven Farmer (Center for Healthcare Innovation and Policy Research, George Washington Universit...

Advantage of guided de-escalation of dual antiplatelet therapy seen in younger patients

A pre-specified analysis of the TROPICAl-ACS study indicates that de-escalating dual antiplatele...

First patient enrolled in phase II of REFLECT study of TriGuard 3

Keystone Heart announced the launch of phase II of the REFLECT trial, which is evaluating the ne...

Ron Waksman

Ron Waksman (MedStar Heart & Vascular Institute, Washington, DC, USA) is the course chairman...

US FDA approve EchoMD AutoEF software for calculating left ventricular ejection fraction

Bay Labs has received US FDA 510(k) clearance for its EchoMD AutoEF software product for the ful...

Caladrius receives FDA regenerative medicine advanced therapy designation for its CD34+ Cell therapy for refractory angina

Caladrius has revealed that the US FDA has granted regenerative medicine advanced therapy (RMAT) des...

EuroPCR 2018: Study indicates “almost perfect agreement” between CT angiography and conventional angiography for revascularisation decisions

A new study, SYNTAX III REVOLUTION, has found heart teams using computed tomography (CT) angiogr...

EuroPCR 2018: Both immediate and delayed approaches seem to work for transient STEMI patients

A new study indicates that a delayed approach in patients with transient ST-segment elevation my...

Combination of high-sensitive C-reactive protein with logistic EuroSCORE improves risk stratification in TAVI patients

According to Anja Stundl (Department of Medicine II, Heart Center Bonn, University Hospital, Bon...

EuroPCR 2018: Will SPYRAL-ON change my practice?

In this PCR video, David E Kandzari (Department of Interventional Cardiology, Piedmont Heart Institu...

Consider patients’ risk of ischaemic stroke when choosing antiplatelet therapies after PCI

New data from ADAPT-DES, published in JACC: Cardiovascular Interventions, indicate that higher p...

EuroPCR 2018: Low incidence of cardiovascular mortality with Centera self-expanding valve at one year

Hermann Reichenspurner (Departments of Cardiovascular Surgery and General and Interventional Car...

Corindus receives Japanese PMDA approval for its CorPath GRX system

Corindus Vascular Robotics has received Pharmaceutical and Medical Device Agency (PMDA) approval...

EuroPCR 2018: No significant difference in bioprosthetic valve dysfunction between surgical and TAVI devices at six years

The NOTION trial (Nordic aortic valve intervention) was the first comparison of surgical and tra...

EuroPCR 2018: Real-world data confirm trial outcomes for Sapien 3

Thirty-day data presented at EuroPCR (22 May—25 May, Paris, France) show consistently positive p...

Cardiology societies come together to provide key advice for dealing with ionising radiation

The American College of Cardiology (ACC), Heart Rhythm Society (HRS), North American Society for...

EuroPCR 2018: FFR-guided PCI reduces spontaneous myocardial infarction

Five-year data from FAME (Fractional Flow Reserve vs. Angioplasty for Multivessel Evaluation) 2 ...

Looks do matter—patients claim what doctors wear is important

According to a study published in BMJ Open, just over half of patients think what a doctor wears...

Cardiovascular News Issue 49—May 2018 US edition

For our May 2018 edition (Issue 49), we report on the key studies from the 2018 American College of ...

Cardiovascular News Issue 49—May 2018

For our May 2018 edition (Issue 49), we report on the key studies from the 2018 American College of ...

BCS 2018: Novel blood test for myocardial infarction could be used in portable device

Data presented at the British Cardiovascular Society Conference (4–6 June, Manchester, UK) indicate ...

Biomerics acquires FutureMatrix Interventional

Biomerics has bought FutureMatrix Interventional, which specialises in the design and manufacture of...

US FDA classifies HeartWare HVAD power issues as a Class I recall

The US FDA has classified Medtronic’s recent voluntary urgent field action related to the HeartW...

EuroPCR 2018: New ORBITA analysis finds iFR/FFR values do not predict impact of PCI on exercise time

New data from the ORBITA trial indicates percutaneous coronary intervention (PCI) does not signi...

ADVERTORIAL: Sentinel Cerebral Protection System provides reassurance to both physicians and patients

Compared with first-generation devices, new-generation transcatheter aortic valve implantation (...

EuroPCR 2018: Data confirms long-term safety and efficacy of Angiolite drug-eluting stent

At EuroPCR (22 May–25 May, Paris, France), the 12-month results of the ANGIOLITE trial were pres...

EuroPCR 2018: PiCSO therapy reduces infarct size in acute myocardial infarction patients

The clinical results from the OxAMI-PiCSO study—published in EuroIntervention and presented at E...

The European Commission authorise use of evolocumab to reduce risk of myocardial infarction in patients with established cardiovascular disease

The European Commission (EC) has authorised a new indication in the evolocumab (Repatha, Amgen) ...

EuroPCR 2018: Interim nine-month results for Magnitude presented

Amaranth Medical provided an update on its sirolimus-eluting bioresorbable scaffold products during ...

Positive clinical results from eCOBRA study

CeloNova BioSciences has announced one-year clinical trial results from the eCOBRA post-market s...

EuroPCR 2018: One- to two-year landmark analysis shows significantly lower target lesion failure with Orsiro vs. Resolute Integrity

Two-year outcome data from the BIO-RESORT randomised controlled trial, which were presented in a...

EuroPCR 2018: Strong early vessel healing with Resolute Onyx in one-month DAPT study

Investigators unveiled clinical data from the independently run Onyx 1-Month OCT Study, which sh...

EuroPCR 2018: DIAB8 randomised study to compare Cre8 Evo with everolimus-eluting stents in diabetic patients

Alvimedica unveiled the details of the Diab8 study—the first diabetic drug-eluting stent randomised ...

ADVERTORIAL: Taking control of LDL-C when statin therapy is not enough

This content is for distribution within the UK only. This content is for distribution wit...

Xience Sierra approved for use in USA

Abbott has announced it has received approval from the US FDA for its Xience Sierra, the newest ...

EuroPCR 2018: Further evidence for safety and efficacy of Magmaris bioresorbable scaffold

Data presented during EuroPCR (22 May – 25 May, Paris, France) provide further evidence on its c...

EuroPCR 2018: Positive data for renal denervation reignites interest in field

After two studies indicated that renal denervation lowers blood pressure both with and without a...

EuroPCR 2018: Two studies provide support for HeartFlow Analysis

New data from the PACIFIC study presented at EuroPCR (22 May – 25 May, Paris, France) showed that th...

Intravascular Lithotripsy for coronary artery disease launched in Europe

Intravascular Lithotripsy (Shockwave Medical) is now available, on the European market, for the mana...

“Excellent valvular function” with NaviGate’s GATE tricuspid valved stent at one year

A press release reports that the first patient to receive the GATE tricuspid valved stent (NaviGate)...

Enrolment of US early feasibility study of AccuCinch system for left ventricular repair expanded

Ancora Heart has announced the expansion of its US feasibility study to evaluate the investigati...

EuroPCR 2018: Boston Scientific outlines its key presentations

Boston Scientific Corporation has revealed its schedule of key presentations—including two late-...

First patient treated in first-in-man study of ChordArt mitral valve repair system

CoreMedic has announced the start of the first-in-man Chagall study to evaluate the new minimally-in...

Use of Resolute Onyx to be explored for the treatment of bifurcation lesions

Medtronic has announced the initiation of a clinical study in the US to assess the safety and ef...

EuroPCR 2018: First-in-human study of Leaflex Performer for aortic stenosis initiated

Pi-Cardia has recently started its first-in-human study with its Leaflex Performer catheter system. ...

Signal that left radial access reduces the risk of PCI-related stroke

A new study shows that patients who undergo percutaneous coronary intervention (PCI) via left ra...

CoreValve shows “favourable performance” at long-term follow-up

Erik W Holy (Heart Center, Segeberger Kliniken, Bad Segeberg, Germany) and others report in Euro...

Cardiac Dimensions appoints Matthew Stark as vice president of Clinical and Regulatory Affairs

Cardiac Dimensions has appointed Matthew Stark as vice president of clinical and regulatory affairs,...

Japan’s Ministry of Health Labour and Welfare grants national reimbursement for Xience Sierra

Abbott has announced that Japan’s Ministry of Health Labour and Welfare (MHLW) has granted national ...

Only 16% of patients participate in a formal exercise programme after cardiac hospitalisation

According to a study published in Circulation, among more than 230,000 cardiac patients who had ...

Cardioband becomes first-ever transcatheter tricuspid system to receive the CE mark

Edwards Lifesciences has received the CE mark for the Cardioband tricuspid valve reconstruction ...

SCAI 2018: David A Cox becomes Society’s new president

David A Cox, (Brookwood Baptist Health, San Antonio, USA; Cardiovascular Associates of the Southeas...

SCAI 2018: 3D model could be used to predict paravalvular leak after TAVI

A new study presented at the 2018 Society for Cardiovascular Angiography and Interventions (SCAI...

Ticagrelor may be an effective tool for suppressing platelet reactivity after TAVI

Speaking at the 2018 CRT meeting (3–6 March, Washington, DC), Victor Alfonso Jiménez Díaz (Cardi...

Non-emergent, uncomplicated target lesion revascularisation significantly increases mortality

Patients who require non-emergent, uncomplicated target lesion revascularisation after percutane...

TMVI in inoperable patients is feasible but mortality high at one year

One-year outcome data for transcatheter mitral valve implantation (TMVI), in inoperable patients...

Terumo receives CE mark for Ultimaster Tansei drug-eluting stent

Terumo has received the CE mark for its Ultimaster Tansei drug-eluting stent. Building on the Ul...

Take care from start to finish: Avoiding radial artery occlusion

Root cause analysis of radial occlusion points to vessel trauma. An ultrasound study by Costa et al ...

TAVI is increasingly seen as the preferred approach for aortic valve replacement in CABG patients

A review of the trends in the use and propensity-matched analysis of in-hospital outcomes, publi...

From the heart of the Andes to the hearts of children

Roberto Canessa is one of 16 survivors from Uruguayan Air Force Flight 571, which crashed into t...

Study to explore shortest-ever duration of triple therapy after PCI

The COBRA REDUCE trial is exploring the safety and efficacy of prescribing dual antiplatelet the...

Intravascular lithotripsy: A novel technology for treating calcified coronary stenoses

Intravascular lithotripsy, or IVL (Shockwave), is a novel procedure that is designed to deliver ...

Boston Scientific successfully opposes Edwards Lifesciences Corporation’s European patent EP 2,399,550 (550)

According to a press release, Boston Scientific has, along with several other opponents, success...

CE mark for HeartStitch’s transapical access and closure device

A press release reports that HeartStitch transapical access and closure device provides safe and eff...

Medtronic appoints Laura Mauri as vice president, Global Clinical Research & Analytics

Medtronic has announced that Laura Mauri—interventional cardiologist and clinical researcher at the ...

Women are still less likely to receive high-intensity statin therapy after myocardial infarction

New data show that, after a myocardial infarction, significantly fewer women than men fill a pre...

Location of tricuspid regurgitation predicts procedural success of percutaneous edge-to-edge repair

Supporting the results of previous studies, a new study indicates that percutaneous edge-to-edge...

A third of patients do not disclose their use of complementary therapy to physicians

A new study indicates that just over a third of patients with cardiovascular disease use some fo...

GUIDE-HF trial to evaluate whether CardioMEMS can improve survival and quality of life for people with NYHA Class II–IV heart failure

Abbott has initiated the landmark GUIDE-HF clinical trial using the CardioMEMS HF system. The GU...

Abiomed receives FDA approval for Impella CP with SmartAssist and Optical Sensor

Abiomed has received US FDA premarket approval (PMA) for its Impella CP heart pump with SmartAss...

US FDA approves Cardioform septal occluder for PFO closure to prevent recurrent ischaemic stroke

Following the results of the Gore REDUCE clinical study, which found that closure of patent fora...

New trial of Symplicity Spyral approved

Medtronic has announced US FDA approval to begin an investigational device exemption (IDE) pivot...

Study of next-generation JenaValve device completes enrolment

A press release reports that successful patient enrolment in the CE mark study of the next-gener...

CIT 2018: BIOFLOW-VI confirms non-inferiority of Orsiro to Xience

Nine and 12-month data for Orsiro—presented by Yang Yue Jin (Fu-Wai Hospital, National Center of...

Enrolment complete in CT imaging substudy of leaflet mobility with Sapien 3 in low-risk patients

Edwards Lifesciences has announced that enrolment is complete in the computed tomography (CT) im...

First two patients enrolled in early feasibility study of second-generation Colibri valve

Colibri Heart Valve has announced that the first two patients have been successfully enrolled in...

UK Court of Appeal dismisses Edwards Lifesciences’ appeal against Sapien 3 infringement ruling

Acurate neo Boston Scientific has announced the UK Court of Appeal  dismissed Edwards Lifesc...

Rome hospital to participate in European DuraGraft registry

The European Hospital in Rome has become the first site in Italy to participate in the DuraGraft Eur...

Justin Davies

Justin Davies (Imperial College London, London, UK) has always been interested in computer progr...

More non-cardiac death explains higher rate of post-PCI mortality in females

According to a new study, the higher rate of all-cause mortality after percutaneous coronary int...

Evidence of substance abuse found in 10% of young myocardial infarction patients

Data from the YOUNG-MI registry indicate that 10% of young myocardial infarction patients (≤50 y...

Determining valve durability in the era of TAVI

Transcatheter aortic valve implantation (TAVI) has progressed from being a procedure that was so...

ACC 2018: Short-term DAPT after PCI in acute coronary syndrome patients is not safe

Data from the SMART-DATE study indicate that acute coronary syndrome patients who receive short-...

ACC 2018: Morphologic characteristics may determine benefit of percutaneous PFO closure

A new study—presented at the American College of Cardiology (ACC) Scientific Session (10–12 March, O...

ADVERTORIAL: “All patients” should receive cerebral protection when undergoing TAVI procedures

Data indicate that patients who undergo TAVI with the Sentinel Cerebral Protection System (Claret Me...

Enrolment complete in BIOSTEMI study

Biotronik has announced that patient enrolment for the BIOSTEMI study has been completed. A pres...

ACC 2018: Using iFR over FFR saves US$896 per patient per year

Economic data from the DEFINE FLAIR clinical trial indicate that using instantaneous wave-free ratio...

ACC 2018: Five-year data for CoreValve show strong haemodynamic performance

New data from the CoreValve US Pivotal Extreme Risk Study and the real-world NOTION trial (Nordi...